Delivery Order SPE2DB20D3103-SPE2DB25FP8L2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $33,098.70 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine products, with a completion date of May 7, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,495.69 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Menveo vaccine (1 vial A-C-Y-W-135-DIP 0.5ML), with completion scheduled for June 20, 2025. This competitive award carries no set-aside designation and utilizes firm fixed pricing under a delivery order contract type. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $175,856.28 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. The contract is scheduled for completion by June 23, 2025, and performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under an existing indefinite delivery contract vehicle, reflecting...
- The Defense Logistics Agency awarded a $10,757.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product. The order is scheduled for completion by September 22, 2025, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under an existing contract vehicle and does not utilize a set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine, with a ceiling value of $6,449.00. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8L2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine products, with a ceiling value of $119,112.76. This firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded on a competitive basis with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal procurement requirements through open competition. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The parent contract serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates extensive experience supplying critical medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning the company as a major pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $119.1k | 8/12/25 |